ASX Announcement

Media Release-US FDA review for SCENESSE extended 3 months

Published: 03/06/19, 10:07am (AEST)3 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only